Cryo-Cell International said it posted a lower net loss for the third quarter of the year compared to the same period in 2007, owing to the cuts in marketing, general and administrative expenses, as well as research and development costs. The private cord blood bank spent $68,000 in the third quarter on its C'elle technology, which allows women to collect and store stem cells harvested from menstrual flow.

Related Summaries